Drug class in one race
SGLT2 drugs for Chronic Kidney Disease
3 tracked SGLT2 drugs in the Chronic Kidney Disease race. The class explanation lives on the SGLT2 page; the full indication pipeline across every mechanism is on the Chronic Kidney Disease page.
3 approved / phase 4
Head-to-head evidence: Canagliflozin vs Dapagliflozin · Canagliflozin vs Empagliflozin · Dapagliflozin vs Empagliflozin